PRME
Prime Medicine Inc.
Company Overview
| Mkt Cap | $648.65M | Price | $4.94 |
| Volume | 6.66M | Change | +13.56% |
| P/E Ratio | -3.3 | Open | $4.37 |
| Revenue | $3.0M | Prev Close | $4.35 |
| Net Income | $-195.9M | 52W Range | $1.11 - $6.94 |
| Div Yield | N/A | Target | $6.78 |
| Overall | 49 | Value | 50 |
| Quality | 39 | Technical | 60 |
No chart data available
Stock Overview
Updated DailyPrime Medicine Inc. (PRME) is a leading diversified company in the business industry, currently trading at $4.94 with a market capitalization of $648.65 million. The stock is positioned in the upper portion of its trading range, demonstrating concerning quality fundamentals with a MarketXLS quality score of 39.
Today's trading session shows PRME with a volume of 6.66 million shares. The stock opened up 0.46% from yesterday's close of $4.35. Current analyst estimates project earnings of $-1.25 per share for this year, with next year targeting $-1.
PRME demonstrates positive technical signals based on technical analysis. The company trades on the NSD exchange.
Key investment considerations for PRME include below-average investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 37.2%. The stock shows neutral valuation indicators based on valuation analysis.
Analysis generated on November 3, 2025 at 10:59 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PRME | $4.94 | +13.6% | 6.66M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |